Literature DB >> 21477168

The utility of breast MRI as a problem-solving tool.

Edwin J Yau1, Robert L Gutierrez, Wendy B DeMartini, Peter R Eby, Sue Peacock, Constance D Lehman.   

Abstract

Breast magnetic resonance imaging (MRI) is routinely used as a problem-solving tool, but its benefit for this indication remains unclear. The records of 3001 consecutive breast MR examinations between January 1, 2003 and June 6, 2007 were reviewed to identify all those performed for the clinical indication of problem solving. Details of clinical presentation, mammography and ultrasound (US) findings, follow-up recommendations, and pathology outcomes were recorded. Benign versus malignant outcomes were determined by biopsy or 12 months of follow-up imaging and linkage with the regional tumor registry. Problem solving was the clinical indication for 204 of 3001 (7%) of all examinations. Forty-two of 204 examinations (21%) had suspicious or highly suspicious MRI assessments with recommendation for biopsy and 62 of 204 (79%) examinations were assessed as negative, benign, or probably benign. Thirty-six biopsies were performed based on MRI findings and 14 cancers were diagnosed. Biopsy was indicated for 11 of 14 (79%) cancers based on suspicious mammographic or US findings identified prior to MRI. One incidental cancer was detected by MRI alone in a patient at high risk for breast cancer, and two cancers were detected in patients with suspicious nipple discharge and negative mammogram and US. A single false-negative MRI occurred in a patient whose evaluation for a palpable lump prompted biopsy. Problem-solving breast MRI rarely identifies otherwise occult cancer and can be falsely negative in patients with suspicious findings on mammogram and US. Until the benefits and risks of problem-solving MRI are clarified, it should be used judiciously.
© 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21477168     DOI: 10.1111/j.1524-4741.2011.01075.x

Source DB:  PubMed          Journal:  Breast J        ISSN: 1075-122X            Impact factor:   2.431


  6 in total

1.  Is there a role for magnetic resonance imaging in diagnosing palpable breast masses when mammogram and ultrasound are negative?

Authors:  Molly L Olsen; Marilyn J Morton; Daniela L Stan; Sandhya Pruthi
Journal:  J Womens Health (Larchmt)       Date:  2012-10-09       Impact factor: 2.681

2.  Outcomes of Canceled Tomosynthesis-Guided Biopsy of Architectural Distortion Due to Nonvisualization.

Authors:  Kelly S Myers; Eniola T Oluyemi; Lisa A Mullen; Babita Panigrahi; Philip A Di Carlo; Derek L Nguyen; Emily B Ambinder
Journal:  J Breast Imaging       Date:  2022-06-20

Review 3.  Multiparametric MR Imaging of Breast Cancer.

Authors:  Habib Rahbar; Savannah C Partridge
Journal:  Magn Reson Imaging Clin N Am       Date:  2016-02       Impact factor: 2.266

4.  Guideline-inconsistent breast cancer screening for women over 50: a vignette-based survey.

Authors:  Hajar Kadivar; Barbara A Goff; William R Phillips; C Holly A Andrilla; Alfred O Berg; Laura-Mae Baldwin
Journal:  J Gen Intern Med       Date:  2013-08-14       Impact factor: 5.128

Review 5.  Diagnostic Performance of Breast Magnetic Resonance Imaging in Non-Calcified Equivocal Breast Findings: Results from a Systematic Review and Meta-Analysis.

Authors:  Barbara Bennani-Baiti; Nabila Bennani-Baiti; Pascal A Baltzer
Journal:  PLoS One       Date:  2016-08-02       Impact factor: 3.240

Review 6.  Expanding the indications for MRI in the diagnosis and treatment of breast cancer: what is best practice?

Authors:  Christobel Saunders; Donna Taylor
Journal:  J Med Radiat Sci       Date:  2015-01-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.